NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons
Go back to NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons| (NASDAQ: NRSN) | Delayed: 5.10 -1.85 (26.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $ | |||
| Open | $6.91 | 52 Week Low | $ | |||
| Day High | $7.15 | P/E | N/A | |||
| Day Low | $4.93 | EPS | $ | |||
| Volume | 61,737 | |||||
